🚀 go-pugleaf

From: MJB1@VMS-SUPP.CAM.AC.UK

Bulletin_# 62  From:  SEQNET  19 Jan 88  Common Data Submission Policy
Subject: Common Data Submission Policy
From: SEQNET
Date: 19 Jan 88

               COMMON DATA SUBMISSION POLICY

The major Nucleic Acid and Protein Sequence Database Centres have agreed a
common data submissions policy.  Under this policy, data submitted to any one
of the participating members will be shared by all others.  As submitted data
will be directly transmitted by the databases, research scientists need submit
data to only one of these groups.

The groups are:
GenBank Genetic Sequence Data Bank (GENBANK)
genbank%arpa.bionet-20@uk.ac.rl.earn

European Molecular Biology Laboratory (EMBL)
datasubs%embl@uk.ac.rl.earn

DNA Data Bank of Japan (DDBJ)
National Institute of Genetics

National Biomedical Research Foundation (NBRF-PIR)
Protein Information Resource
pirsub%gunbrf@uk.ac.rl.earn

Martinsreid Institute for Protein Sequence Data (MIPS)
Max Planck Institute for Biochemistry
mips%dm0mpb51@uk.ac.rl.earn

International Protein Information Database in Japan (JIPID)
Science University of Tokyo

Please fill in the forms provided for submitting your entry.
A program to aid proper completion of forms is expected soon.
===============================================================================
  Your name
 ------------------------------------------------------------------------------
  Organization
 ------------------------------------------------------------------------------
  Address



 ------------------------------------------------------------------------------
  Telephone                     Computer network address
 ==============================================================================
  On what medium and in what format are you sending your sequence data? (see
  end of this form for instructions)
      [ ] magnetic tape: density   [ ] 800  [ ] 1600   [ ] 6250
                         character code  [ ] ASCII  [ ] EBCDIC
                         record length ______________ blocksize ______________
                         label type _________________
      [ ] electronic mail
      [ ] diskette: computer ________________ operating system _______________
      [ ] printed copy
===============================================================================


CITATION INFORMATION

===============================================================================
  These data will be published by
  authors
 ______________________________________________________________________________
  title of paper
 ______________________________________________________________________________
  journal
 ------------------------------------------------------------------------------
  vol, pages,year (if known)
 ==============================================================================
  Does the sequence which you are sending with this form include data that
  does not appear in the above journal article?
     [ ] yes, beginning at base number _____ and ending at base _____   [ ] no
  How should this data be cited in the database?
     authors
 ------------------------------------------------------------------------------
     title of paper (if applicable)
 ------------------------------------------------------------------------------
     journal (if applicable)                       vol,pages,year
 ==============================================================================
  Please list references to papers and/or database entries which report
  sequences overlapping with data submitted here.
 ------------------------------------------------------------------------------
     first author     journal, vol., pages, year OR database, accession number
 ------------------------------------------------------------------------------

 ------------------------------------------------------------------------------

 ==============================================================================


DESCRIPTION OF SEQUENCED SEGMENT

Where appropriate, please use standard nomenclature or conventions. NOT ALL
QUESTIONS ARE RELEVANT TO ALL SEQUENCES.
===============================================================================
 What kind of molecule does this sequence represent?

  [ ] genomic DNA                                      [ ] tRNA
  [ ] organelle DNA (please specify) ______________    [ ] rRNA
  [ ] cDNA                                             [ ] snRNA
  [ ] other nucleic acid __________________________    [ ] scRNA

  [ ] peptide
      sequence assembled by  [ ] overlap of sequenced fragments
                             [ ] homology with related protein sequence
                             [ ] other (please specify) _____________________
-------------------------------------------------------------------------------
 length of sequence          [ ] bp   or   [ ] amino acid residues
-------------------------------------------------------------------------------
 library (type, name)                      clone(s)
-------------------------------------------------------------------------------
 genomic location/map position             gene name(s) (e.g., lacZ)
-------------------------------------------------------------------------------
 gene product name(s) (e.g., beta-D-galactosidase) and Enyme Commission number

-------------------------------------------------------------------------------
 source organism (Latin name) (e.g., Mus musculus)
-------------------------------------------------------------------------------
 strain (e.g., BALB/c)                     haplotype
-------------------------------------------------------------------------------
 tissue/cell line source                   [ ] germ line     [ ] rearranged
===============================================================================


FEATURES OF THE SEQUENCE

Please list below the first and last base/residue numbers of all significant
features identified within the sequence.  In the column marked "id," indicate
the method by which the feature was identified (E = experimentally; S = by
similarity with another sequence; C = match to an established consensus
sequence).  For nucleotide sequences, indicate (by writing an x in the column
marked "comp") if the feature is encoded by the strand complementary to that
reported here.

Some examples of significant features are:

  - regulatory signals (e.g., promoters, attenuators, enhancers)
  - transcribed regions (mRNA, rRNA, tRNA, etc.)
  - regions subject to post-transcriptional modification (e.g., introns,
    modified bases)
  - translated regions
  - extent of signal peptide, prepropeptide, propeptide, mature peptide
  - sites subject to post-translational modification (glycosylation,
    phosporylation)
  - other domains/sites of interest (e.g., extracellular domain, DNA-binding
    domain, active site, inhibitory site)
  - sites involved in bonding (disulfide, thiolester, intrachain, interchain)
  - regions of alpha helix or beta pleated sheet

================================================================================
   Numbering for features on the sequence you are submitting to us
       [ ] starts at 1   OR    [ ] starts at _______
   Does the numbering match that in your manuscript?   [ ] yes   [ ] no
--------------------------------------------------------------------------------
                   feature                    from       to       id     comp
------------------------------------------- --------- ---------  ----- ---------

------------------------------------------- --------- ---------  ----- ---------

------------------------------------------- --------- ---------  ----- ---------

------------------------------------------- --------- ---------  ----- ---------

------------------------------------------- --------- ---------  ----- ---------

------------------------------------------- --------- ---------  ----- ---------

------------------------------------------- --------- ---------  ----- ---------

------------------------------------------- --------- ---------  ----- ---------

------------------------------------------- --------- ---------  ----- ---------

------------------------------------------- --------- ---------  ----- ---------

------------------------------------------- --------- ---------  ----- ---------

================================================================================



KEYWORDS

===============================================================================
Describe the properties of the sequence in terms of its associated
phenotype(s), the biological/enzymatic activity of its product and the general
functional classification of the gene and/or gene product.  Also indicate
macromolecules which the gene product can bind (e.g., DNA; Ca++; other
proteins), subcellular localization of the gene product and any other
information you think is relevant.

EXAMPLE (for the viral erbB gene sequence): transforming capacity;
EGF receptor-related; transmembrane protein; tyrosine kinase; oncogene.
-------------------------------------------------------------------------------



===============================================================================